Sökning: "Oncology"

Visar resultat 1 - 5 av 1202 avhandlingar innehållade ordet Oncology.

  1. 1. Radiolabeled acetate PET in oncology imaging studies on head and neck cancer, prostate cancer and normal distribution

    Detta är en avhandling från Umeå : Umeå university

    Författare :Aijun Sun; Umeå universitet.; [2010]
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; 11C-acetate; 18F-fluoroacetate; PET; head and neck cancer; staging; delineating tumor volume; clearance rate; perfusion; RT; treatment outcome; benign and malignant lymph node; prostate cancer; normal distribution; MEDICINE Surgery Oncology; MEDICIN Kirurgi Onkologi; onkologi; Oncology;

    Sammanfattning : The use of positron emission tomography (PET) for imaging in oncology has grown rapidly in recent years. 2-[18F]-fluorodeoxyglucose (FDG) is the most common tracer of PET, although drawbacks exist. LÄS MER

  2. 2. Quality improvement in palliative care the role of a national quality register and perceptions of information during palliative chemotherapy

    Detta är en avhandling från Umeå : Umeå universitet

    Författare :Lisa Martinsson; Umeå universitet.; [2015]
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Cancer; chemotherapy; communication; end-of-life care; oncology; palliative care; palliative medicine; quality in healthcare; quality register; onkologi; Oncology;

    Sammanfattning : IntroductionThere is a need in palliative care for development of structured methods to assess quality and support improvement. This need is present both within and outside specialised palliative care.Honest information from physicians is regarded as an important part of palliative care. LÄS MER

  3. 3. Copy Number Analysis of Cancer

    Detta är en avhandling från Uppsala : Acta Universitatis Upsaliensis

    Författare :Markus Mayrhofer; Uppsala universitet.; [2015]
    Nyckelord :NATURVETENSKAP; NATURAL SCIENCES; NATURVETENSKAP; NATURAL SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; chromosomes; oncology; bioinformatics; Bioinformatik; Bioinformatics; Oncology; Onkologi; Clinical Genetics; Klinisk genetik;

    Sammanfattning : By accurately describing cancer genomes, we may link genomic mutations to phenotypic effects and eventually treat cancer patients based on the molecular cause of their disease, rather than generalizing treatment based on cell morphology or tissue of origin.Alteration of DNA copy number is a driving mutational process in the formation and progression of cancer. LÄS MER

  4. 4. Studies on the occurrence and effects of human papillomavirus in tumors of the head and neck

    Detta är en avhandling från Stockholm : Karolinska Institutet

    Författare :David Lindquist; Karolinska Institutet.; Karolinska Institutet.; [2008]
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; onkologi; Oncology;

    Sammanfattning : The presence of human papillomavirus (HPV) in squamous cell carcinoma of the head and neck (HNSCC) was first reported in 1985. Since then, this association has been studied intensively and today there is substantial evidence for HPV as a causative agent and positive prognostic factor for clinical outcome in tonsillar cancer, but the association to other HNSCC is still unclear. LÄS MER

  5. 5. Aggressive B-cell Lymphomas Studies of Treatment, FDG-PET Evaluation and Prognostic Factors

    Detta är en avhandling från Uppsala : Acta Universitatis Upsaliensis

    Författare :Magdalena Adde; Uppsala universitet.; [2009]
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICINE Surgery Oncology; MEDICIN Kirurgi Onkologi; Oncology; Onkologi;

    Sammanfattning : To improve outcome in young, high-risk lymphoma patients, treatment was intensified, adding etoposide and rituximab to standard CHOP treatment. Granulocyte-colony stimulating factor (G-CSF) enabled treatment bi-weekly. Results were promising: overall (OS) and event-free survival (EFS) 79% and 60% respectively, median follow up 27 months. LÄS MER